Nanobiotechnology--quo vadis?
Dow Europe GmbH, 8810 Horgen, Switzerland. RJKOOPMANS@dow.com
Rudolf J
RJ
Koopmans
Amalia
A
Aggeli
D001709:Biotechnology / Q000639:trends*; D006801:Humans; D053758:Nanoparticles / Q000706:statistics & numerical data; D036103:Nanotechnology / Q000639:trends*; D013501:Surface-Active Agents / Q000378:metabolism; D023822:Tissue Engineering / Q000379:methods
D013501:Surface-Active Agents